Life Stem Genetics Inc. (OTCPK: LIFS)
Health Care · Health Care Providers & Services · US
$0.00
-66.67% today · 0.0% 1Y
Life Stem Genetics Inc. (OTCPK: LIFS) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $24.58K and employs 0 people.
Over the last twelve months the share price has gained 0.0%, trading between 0.00 and 0.00.
LIFS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $24.58K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 2.23
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 245.84M
- Employees
- 0
- Next earnings
- —
About Life Stem Genetics Inc.
Life Stem Genetics Inc., an enterprise currently in its development phase, is focused on establishing a global network of clinics that specialize in stem cell therapy. Its comprehensive suite of offerings includes nutraceuticals, medical supplements, and intravenous nutritional cocktails, in addition to stem cell banking services. The company provides a variety of stem cell treatments addressing degenerative conditions, cancer, and weight management, alongside anti-aging and anti-viral therapies. Also available are Adistem stem cell treatments tailored for orthopedic, neurological, and lung diseases, as well as hyperbaric oxygen therapy. Life Stem Genetics Inc. maintains a strategic collaborative agreement with American CryoStem Corporation. This company was founded in 2012 and operates from its base in Beverly Hills, California.
- ISIN
- US53217Y1038
- Founded
- 2012
- Listed since
- Oct 22, 2013
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $350.16B | $395.70 | +1.43% |
| CVS Health CorporationNYSE: CVS | $118.97B | $92.92 | -0.11% |
| McKesson CorporationNYSE: MCK | $100.14B | $874.46 | +1.81% |
| HCA Healthcare, Inc.NYSE: HCA | $92.92B | $430.51 | +0.31% |
| Elevance Health, Inc.NYSE: ELV | $86.86B | $401.57 | +0.26% |
| The Cigna GroupNYSE: CI | $73.33B | $278.24 | +0.26% |
| Cencora, Inc.NYSE: COR | $60.69B | $323.97 | +1.86% |
| Cardinal Health, Inc.NYSE: CAH | $53.38B | $232.11 | +1.13% |
Figures last refreshed Aug 18, 2026.